• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back To Search Results
Recognition List Number: 033 FR Publication Date: 01/14/2014 

Part B: Supplementary Information

Recognition Number 12-207: IEC 60601-2-33 Edition 3.0 2010-03, medical electrical equipment - part 2-33: particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnostic. (Radiology)

Date of Standard: 2010. 
Address of Standards Development Organization:
 International Electrotechnical Commission (IEC)
  3, Rue de Varembe'
  PO Box 131
  CH-1211 Geneva 20, 0
CDRH Office and Division associated with recognized standards:
Devices Affected:
Magnetic Resonance Imaging Systems, Magnetic Resonance Spectroscopic Systems, Magnetic Resonance Specialty Coils
Processes Affected:
510(k), PMA, PDP, IDE, HDE
Type of Standard:
 Vertical, International
Extent of Recognition:
Complete standard and any annexes.

FDA recognition of IEC 60601-2-33 Edition 3.0 2010-03 [Rec# 12-207] will be superseded by recognition of IEC 60601-2-33 Edition 3.1 [Rec# 12-271]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec # 12-207] until August 1, 2016. After this transition period, declarations of conformity to [Rec # 12-207] will not be accepted.
Related CFR Citations and Product Codes:
Device Name Device
§892.1000 Coil, Magnetic Resonance, Specialty Class 2 MOS
§892.1000 Magnetic Resonance Imaging Disposable Kit Class 2 OIM
§892.1000 System, Nuclear Magnetic Resonance Imaging Class 2 LNH
§892.1000 System, Nuclear Magnetic Resonance Spectroscopic Class 2 LNI
Relevant Guidance:
Guidance for Industry
Guidance for the Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices. Document issued on: November 14, 1998

Guidance for Industry and FDA Staff Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. Document issued on: July 14, 2003
FDA Technical Contact:
 Wolfgang Kainz
  10903 New Hampshire Avenue Building 62, Room 1132
  Silver Spring MD 20993
  email: wolfgang.kainz@fda.hhs.gov
* in the United States, copies of this standard can be obtained from:
  American National Standards Institute (ANSI)*
  25 West 43rd Street
  4th Floor
  New York, NY 10036